ESG

We suggest proper health through the daily lives and lifelong journeys of our customers.

Board of Directors

The Board of Directors at Samil Pharmaceutical diligently fulfills its responsibilities in compliance with relevant laws, regulations, and the Company’s Articles of Incorporation. The Board is tasked with making key management decisions and effectively overseeing management and directors to act in the best interests of the Company and its shareholders.

Board of Directors

Name Experience Date Appointed Term Position
SeungBum Huh
  • Trinity College (US)
  • Chairman and CEO, Samil Pharmaceutical
2022.03.25 3 years CEO
(Full-time)
TaeKeun Kwon
  • Department of Economics, Yonsei University
  • MBA, Seoul National University
  • Head of Business Innovation, Samil Pharmaceutical
  • (Concurrent Position) Director of Business Support
2023.03.24 3 years Internal Director
(Full-time)
JoonBeom Huh
  • Bentley University
  • Head of CHC Business, Samil Pharmaceutical
2022.03.25 3 years Internal Director
(Full-time)
HyungSeok Choi
  • Department of Landscape Architecture, Seoul National University
  • Doctor of Urban Design and Landscape Architecture, Seoul National University
  • Professor at the University of Suwon
2022.03.25 3 years External Director
(Part-time)
ChangHo Kim
  • Department of Business Admistration, Seoul National University
  • George Washington University
  • CPA, Samil Accounting
  • Senior CPA, SHIN & KIM
2022.03.25 3 years External Director
(Part-time)
HyungWook Kim
  • Department of Law, Hankuk University of Foreign Studies
  • School of Law, Yonsei University
  • Deputy Chief Prosecutor, Busan District Public Prosecutors Office
  • Lawyer, Kim HyungWook Law Firm
2023.03.24 3 years External Director
(Part-time)

Committee within the BOD (Audit Committee)

Classification Name Date Appointed Term Remarks
Audit committee members HyungSeok Choi 2022.03.25 3 years External Director
ChangHo Kim 2022.03.25 3 years External Director
(Finance and accounting professional)
HyungWook Kim 2023.03.24 3 years External Director

Current Audit Committee Composition

Classification Name Date Appointed Term Experience Remarks
Audit committee members HyungSeok Choi 2022.03.25 3 years
  • Department of Landscape Architecture, Seoul National University
  • Doctor of Urban Design and Landscape Architecture, Seoul National University
  • Professor at the University of Suwon
External Director
ChangHo Kim 2022.03.25 3 years
  • Department of Business Admistration, Seoul National University
  • George Washington University
  • CPA, Samil Accounting
  • Senior CPA, SHIN & KIM
External Director
HyungWook Kim 2023.03.24 3 years
  • Department of Law, Hankuk University of Foreign Studies
  • School of Law, Yonsei University
  • Busan District Public Prosecutors Office (Deputy Chief Prosecutor)
  • Lawyer, Kim HyungWook Law Firm
External Director

Audit Opinion for the Last 3 Business Years

Business Year Auditors Audit Opinion Remarks
2023 EY Adequate
2022 EY Adequate
2021 EY Adequate

Voting Rights Overview (as of 2023.12.31)

Classification Shares # of Shares Remarks
Outstanding Shares(A) Common Shares 15,226,786 -
Preferred Shares - -
Non-Voting Shares(B) Common Shares 763,908 Treasury Shares
Preferred Shares - -
Shares excluded from exercising voting rights under the Articles of Incorporation(C) Common Shares - -
Preferred Shares - -
Shares with voting rights restricted by other laws(D) Common Shares - -
Preferred Shares - -
Shares with voting rights restored(E) Common Shares - -
Preferred Shares - -
Shares with voting rights(F = A - B - C - D + E) Common Shares 14,462,878 -
Preferred Shares - -

Adoption of E-voting, Voting in writing, and Cumulative voting

Classification Adopted/Not adopted
E-voting and e-proxy Not adopted
Voting in writing Not adopted
Cumulative voting Not adopted

Shareholders' Meeting Agenda and Resolutions (Date: 2024.3.22)

Agenda Classification Resolution classification Approved/Not approved # of voting rights # of Shares For (Percentage) # of Shares Against/Abstained (Percentage)
Agenda #1 Approval of the financial statements and consolidated financial statements for the 71st period (January 1, 2023 to December 31, 2023) Ordinary Approved 4,765,655 4,731,073
(99.27%)
34,582
(0.73%)
Agenda #2 Appointment of internal directors (Candidate: SangJin Kim) Ordinary Approved 4,765,655 4,714,133
(98.92%)
51,522
(1.08%)
Agenda #3 Determination of the limit on director compensation payments Ordinary Approved 4,765,655 4,713,710
(98.91%)
51,945
(1.09%)

Board of Directors

The Board of Directors at Samil Pharmaceutical diligently fulfills its responsibilities in compliance with relevant laws, regulations, and the Company’s Articles of Incorporation. The Board is tasked with making key management decisions and effectively overseeing management and directors to act in the best interests of the Company and its shareholders.

Board of Directors

Name Experience Date Appointed Term Position
SeungBum Huh
  • Trinity College (US)
  • Chairman and CEO, Samil Pharmaceutical
2022.03.25 3 years CEO
(Full-time)
SangJin Kim
  • Drpartment of Pharmacy, Seoul National University
  • President and CEO, Samil Pharmaceutical
2024.03.22 3 years CEO
(Full-time)
TaeKeun Kwon
  • Department of Economics, Yonsei University
  • MBA, Seoul National University
  • Head of Business Innovation, Samil Pharmaceutical
  • (Concurrent Position) Director of Business Support
2023.03.24 3 years Internal Director
(Full-time)
JoonBeom Huh
  • Bentley University
  • Head of CHC Business, Samil Pharmaceutical
2022.03.25 3 years Internal Director
(Full-time)
HyungSeok Choi
  • Department of Landscape Architecture, Seoul National University
  • Doctor of Urban Design and Landscape Architecture, Seoul National University
  • Professor at the University of Suwon
2022.03.25 3 years External Director
(Part-time)
ChangHo Kim
  • Department of Business Admistration, Seoul National University
  • George Washington University
  • CPA, Samil Accounting
  • Senior CPA, SHIN & KIM
2022.03.25 3 years External Director
(Part-time)
HyungWook Kim
  • Department of Law, Hankuk University of Foreign Studies
  • School of Law, Yonsei University
  • Deputy Chief Prosecutor, Busan District Public Prosecutors Office
  • Lawyer, Kim HyungWook Law Firm
2023.03.24 3 years External Director
(Part-time)

Committee within the BOD (Audit Committee)

Classification Name Date Appointed Term Remarks
Audit committee members HyungSeok Choi 2022.03.25 3 years External Director
ChangHo Kim 2022.03.25 3 years External Director
(Finance and accounting professional)
HyungWook Kim 2023.03.24 3 years External Director

Current Audit Committee Composition

Classification Name Date Appointed Term Experience Remarks
Audit committee members HyungSeok Choi 2022.03.25 3 years
  • Department of Landscape Architecture, Seoul National University
  • Doctor of Urban Design and Landscape Architecture, Seoul National University
  • Professor at the University of Suwon
External Director
ChangHo Kim 2022.03.25 3 years
  • Department of Business Admistration, Seoul National University
  • George Washington University
  • CPA, Samil Accounting
  • Senior CPA, SHIN & KIM
External Director
HyungWook Kim 2023.03.24 3 years
  • Department of Law, Hankuk University of Foreign Studies
  • School of Law, Yonsei University
  • Busan District Public Prosecutors Office (Deputy Chief Prosecutor)
  • Lawyer, Kim HyungWook Law Firm
External Director

Audit Opinion for the Last 3 Business Years

Business Year Auditors Audit Opinion Remarks
2023 한영회계법인 적정
2022 한영회계법인 적정
2021 한영회계법인 적정

Voting Rights Overview (as of 2023.12.31)

Classification Shares # of Shares Remarks
Outstanding Shares(A) Common Shares 15,226,786 -
Preferred Shares - -
Non-Voting Shares(B) Common Shares 763,908 Treasury Shares
Preferred Shares - -
Shares excluded from exercising voting rights under the Articles of Incorporation(C) Common Shares - -
Preferred Shares - -
Shares with voting rights restricted by other laws(D) Common Shares - -
Preferred Shares - -
Shares with voting rights restored(E) Common Shares - -
Preferred Shares - -
Shares with voting rights(F = A - B - C - D + E) Common Shares 14,462,878 -
Preferred Shares - -

Adoption of E-voting, Voting in writing, and Cumulative voting

구분 도입여부
E-voting and e-proxy Not adopted
Voting in writing Not adopted
Cumulative voting Not adopted

Shareholders' Meeting Agenda and Resolutions (Date: 2024.3.22)

Agenda Classification Resolution classification Approved/Not approved # of voting rights # of Shares For (Percentage) # of Shares Against/Abstained (Percentage)
Agenda #1 Approval of the financial statements and consolidated financial statements for the 71st period (January 1, 2023 to December 31, 2023) Ordinary Approved 4,765,655 4,731,073
(99.27%)
34,582
(0.73%)
Agenda #2 Appointment of internal directors (Candidate: SangJin Kim) Ordinary Approved 4,765,655 4,714,133
(98.92%)
51,522
(1.08%)
Agenda #3 Determination of the limit on director compensation payments Ordinary Approved 4,765,655 4,713,710
(98.91%)
51,945
(1.09%)